5G6-32789-10979

2 vaccinations 14 coded responses 18 check-ins 14 free-text entries 0 call cases

Sex: Male
Age at first dose: 51-55
ZIP prefix: 280 / NC
Registered: 2021-04-02

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline Vaccinations Free text MedDRA terms

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-01
Dose 1 — Pfizer-BioNTech
2021-04-02
Registered in v-safe
2021-04-02
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work

Free text: Eye pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-03
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain — Feeling: Poor · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Eye pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-04
Survey response — days 1–6 daily, dose 1
MedDRA: Eye pain — Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Eye pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-05
Survey response — days 1–6 daily, dose 1
MedDRA: Asthenopia, Eye pain — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Eye pain / strain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-06
Survey response — days 1–6 daily, dose 1
MedDRA: Asthenia, Balance disorder, Pre-existing disease — Feeling: Poor · Headache, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Very weak, off balance, exercise intolerance. Preexisting brain injury. Very concerned about my second shot into weeks if Im experiencing all of these symptoms after the first one. Please advise.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-07
Survey response — days 1–6 daily, dose 1
MedDRA: Balance disorder, Fatigue, Pre-existing disease — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: No sense of balance whatsoever. Utter fatigue. (Pre-existing brain injury)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-08
Survey response — day 7, dose 1
MedDRA: Eye pain, Migraine with aura — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Migraine with aura, eye pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-15
Survey response — day 14, dose 1
MedDRA: Dizziness, Headache — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Continued headache and eye pain. Dizziness. Pre-existing brain injury. .... Really need to know whether or not to go ahead with my second shot next week?? Have not heard anything at all from my doctor. PLEASE advise.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-23
Health check-in — day 21, dose 1
Feeling: Fair

Adult check-in
2021-04-29
Dose 2 — Pfizer-BioNTech
2021-05-06
Survey response — day 7, dose 2
MedDRA: Eye pain, Headache, Photophobia — Feeling: Poor · Headache, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities

Free text: Pre-existing brain injury. Extreme eye pain. Headaches. Extreme light sensitivity.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-14
Survey response — day 14, dose 2
MedDRA: Eye pain, Headache, Photophobia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Extreme light sensitivity. Eye pain/headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-20
Survey response — day 21, dose 2
MedDRA: Eye pain, Headache, Photophobia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Eye pain, Extreme light sensitivity, headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-27
Survey response — day 28, dose 2
MedDRA: Eye pain, Photophobia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Extreme eye pain. Extreme light sensitivity. Same report for past two months.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-03
Survey response — day 35, dose 2
MedDRA: Eye pain, Fatigue, Headache — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Eye pain, headache and extreme fatigue

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-10
Survey response — day 42, dose 2
MedDRA: Headache, Photophobia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Continuing neurological symptoms (headaches, light sensitivity, noise sensitivity, etc.) Existing brain injury. No advice provided regarding Vaccine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-31
Health check-in — 3 months, dose 2
Feeling: Poor

Adult check-in
2021-10-30
Health check-in — 6 months, dose 2
Feeling: Fair

Adult check-in
2022-04-30
Health check-in — 12 months, dose 2
Feeling: Fair

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-01	Pfizer-BioNTech
2	2021-04-29	Pfizer-BioNTech

Free text

Release 6 — days 1–6 daily, dose 1

2021-04-02

Systemic reaction (other): Eye pain

2021-04-03

Systemic reaction (other): Eye pain

2021-04-04

Systemic reaction (other): Eye pain

2021-04-05

Systemic reaction (other): Eye pain / strain

Release 7 — days 1–6 daily, dose 1

2021-04-06

Systemic reaction (other): Very weak, off balance, exercise intolerance. Preexisting brain injury. Very concerned about my second shot into weeks if Im experiencing all of these symptoms after the first one. Please advise.

2021-04-07

Systemic reaction (other): No sense of balance whatsoever. Utter fatigue. (Pre-existing brain injury)

Release 7 — day 7, dose 1

2021-04-08

Systemic reaction (other): Migraine with aura, eye pain

Release 7 — day 14, dose 1

2021-04-15

Symptoms: Continued headache and eye pain. Dizziness. Pre-existing brain injury. .... Really need to know whether or not to go ahead with my second shot next week?? Have not heard anything at all from my doctor. PLEASE advise.

Release 8 — day 7, dose 2

2021-05-06

Systemic reaction (other): Pre-existing brain injury. Extreme eye pain. Headaches. Extreme light sensitivity.

Release 8 — day 14, dose 2

2021-05-14

Symptoms: Extreme light sensitivity. Eye pain/headache

Release 8 — day 21, dose 2

2021-05-20

Symptoms: Eye pain, Extreme light sensitivity, headache

Release 8 — day 28, dose 2

2021-05-27

Symptoms: Extreme eye pain. Extreme light sensitivity. Same report for past two months.

Release 8 — day 35, dose 2

2021-06-03

Symptoms: Eye pain, headache and extreme fatigue

Release 9 — day 42, dose 2

2021-06-10

Symptoms: Continuing neurological symptoms (headaches, light sensitivity, noise sensitivity, etc.) Existing brain injury. No advice provided regarding Vaccine.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Dizziness	✓	✓	✓
SD	Eye pain	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Photophobia	✓	✓	✓
SRO	Asthenia	✓	✓	✓
SRO	Asthenopia	✓	✓	✓
SRO	Balance disorder	✓	✓	✓
SRO	Eye pain	✓	✓	✓
SRO	Fatigue	✓	✓	✓
SRO	Headache	✓	✓	✓
SRO	Migraine with aura	✓	✓	✓
SRO	Photophobia	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release